Long-term outcome of peanut oral immunotherapy facilitated initially by omalizumab
The Journal of Allergy and Clinical Immunology: In Practice | Oct 05, 2018
Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes
Diabetologia - Clinical and Experimental Diabetes and Metabolism | Sep 30, 2018
Most read this week